Deepinder Goyal, founder of Eternal, plans to launch a bean-shaped wellness wearable called Temple that measures cerebral blood flow [1].
The move marks Goyal's first commercial venture after stepping down from Eternal. By targeting the health-tech sector, he is pivoting toward high-risk experimentation aimed at high-performing individuals [1], [2].
The Temple device is designed to monitor a user's metabolic state and blood flow in the brain [1]. Goyal said the product is not intended for a mass market. "I'm not building Temple for everybody," Goyal said [1].
Timeline estimates for the product's release vary. Some reports suggest the device will launch within one year [1], while others indicate it could be ready in as little as six months [2]. The estimated retail price for the wearable is approximately $1,000 [3].
Beyond the wellness wearable, Goyal is expanding his portfolio into other high-tech sectors. He has made a personal investment of $20 million in LAT Aerospace [2]. This diversification suggests a broader strategy to move beyond the food-tech ecosystem that defined his earlier career with Zomato.
The Temple device represents a shift toward specialized bio-monitoring, a niche market where high-net-worth users pay a premium for granular health data [3].
“"I'm not building Temple for everybody"”
Goyal's entry into the health-tech space with a high-priced, specialized wearable signals a move toward 'bio-hacking' and performance optimization. By focusing on cerebral blood flow rather than general fitness metrics, he is attempting to differentiate his product from mass-market trackers like Apple or Garmin, targeting a demographic that prioritizes cognitive performance over general wellness.
